(2S,4S)-2-[(Benzoyloxy)methyl]-1,3-dioxolane-4-carboxylic Acid is an intermediate used in the synthesis of Troxacitabine (T805580), which is a nucleoside analogue with potential anticancer activity. Troxacitabine have been studied in patients with refractory lymphoproliferative diseases.